Clopidogrel is an anticoagulant commonly used in the prehospital environment for the management of ST-elevation myocardial infarction (STEMI). Some ambulance services have incorporated this into their treatment regimens; however, others hold a variety of alternative pharmacological interventions. This study examines the pharmacological efficacy and safety of clopidogrel in the management of patients with STEMI and explores whether ambulance services should use the drug as part of standard practice. A literature review was conducted to identify articles relating to the administration of clopidogrel in the prehospital setting. Fourteen peer-reviewed journal articles were included in this review, together with and clinical practice guidelines from eight international ambulance jurisdictions. According to this review, clopidogrel has been deemed safe, effective and practical for widespread use in the prehospital environment for the management of STEMI, particularly where there are extended transport times to definitive care facilities. However, some disagreement has arisen over whether clopidogrel is a more favourable anticoagulant than ticagrelor and prasugrel. Anticoagulants such as clopidogrel should be strongly considered as a standard treatment regimen in the prehospital management of STEMI across international jurisdictions.
|Number of pages||10|
|Journal||Journal of Paramedic Practice: the clinical monthly for emergency care professionals|
|Early online date||02 Jun 2021|
|Publication status||Published - 18 Jun 2021|